- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00934284
Effectiveness Study of Physical Therapy As an Adjunct to a Lumbar Therapeutic Selective Nerve Root Block
December 9, 2024 updated by: Anne Thackeray, University of Utah
Effectiveness of Physical Therapy As an Adjunct to a Selective Nerve Root Block in the Treatment of Lumbar Radicular Pain from Disk Herniation
The purpose of this study is to determine if participation in physical therapy in conjunction with a selective nerve root block in the lumbar spine is more effective than just receiving the injection alone for patients with low back and leg pain from a disk herniation (sciatica).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Recent reviews report moderate to strong evidence for short-term relief but limited evidence for long-term improvement.
Anecdotal reports and case studies suggest good outcomes with various physical therapy interventions however well-designed research studies examining treatments in combination are lacking.
The management of lumbar radicular pain often includes the combination of physical therapy and therapeutic selective nerve root blocks with the rationale that reducing inflammation and pain will permit greater participation in physical therapy.
The effectiveness of this combination of treatment has not been studied and is the purpose of this pilot study.
Study Type
Observational
Enrollment (Actual)
44
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84107
- Intermountain Healthcare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 56 years (Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Individuals with low back pain, with clinical and imaging findings consistent with lumbar disk herniation, and scheduled to receive a selective nerve root block.
Description
Inclusion Criteria:
- MRI evidence of disk herniation in the lumbar spine consistent with clinical presentation
- Pain and/or paresthesia in the lumbar spine and a distribution extending distal to the gluteal fold within 24 hours of enrollment
- Scheduled to receive a therapeutic selective nerve root block
Exclusion Criteria:
- Any lumbar surgery within six months of the baseline examination
- Any prior lumbar surgery involving fusion
- Medical red flags indicating a serious pathology such as neoplasm, infection, or fracture
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Injection only
Participants receive a therapeutic selective nerve root block and advice to return to normal activity as tolerated.
|
Patients are instructed to resume normal activity as tolerated.
|
|
Injection plus physical therapy
Participants are referred to physical therapy within one week of receiving a therapeutic selective nerve root block.
Physical therapy consists of end-range movements in a directional preference and/or mechanical traction to reduce radicular symptoms.
|
Participants are referred to an average of four weeks of physical therapy after receiving a lumbar injection.
Physical therapy designed to include end-range directional preference exercises and/or mechanical traction to reduce lower extremity symptoms and progress activity tolerance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Modified Oswestry Disability Index
Time Frame: Baseline (pre-injection), 8 weeks (post-injection), 6 months post-injection
|
Baseline (pre-injection), 8 weeks (post-injection), 6 months post-injection
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Global Rating of Change
Time Frame: 8 weeks (post-injection) and 6 months (post-injection)
|
8 weeks (post-injection) and 6 months (post-injection)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Julie M Fritz, PhD, Associate professor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2006
Primary Completion (Actual)
February 1, 2008
Study Completion (Actual)
February 1, 2008
Study Registration Dates
First Submitted
July 6, 2009
First Submitted That Met QC Criteria
July 7, 2009
First Posted (Estimated)
July 8, 2009
Study Record Updates
Last Update Posted (Actual)
December 13, 2024
Last Update Submitted That Met QC Criteria
December 9, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00014476
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sciatic Neuropathy
-
Riphah International UniversityCompletedSciatic RadiculopathyPakistan
-
University of PalermoCompletedSciatic RadiculopathyItaly
-
Central Finland Hospital DistrictKuopio University Hospital; Seinajoki Central HospitalCompleted
-
Consano BioRecruitingSciatica | Sciatic Radiculopathy | Lumbosacral Radiculopathy | Lumbosacral Radicular Syndrome | Lumbosacral Radicular Pain | Sciatic Leg PainAustralia
-
C.L.A.Vleggeert-LankampSpaarne Gasthuis; Stichting Achmea Gezondheidszor; Posthumus Meyjes FondsRecruitingSciatica | Sciatica Due to Intervertebral Disc Disorder | Sciatic RadiculopathyNetherlands
-
Riphah International UniversityCompleted
-
University of SouthamptonSolent NHS TrustUnknown
-
Guang'anmen Hospital of China Academy of Chinese...Unknown
-
Akdeniz UniversityPamukkale University; Ataturk University; Antalya Training and Research Hospital and other collaboratorsUnknown
-
BiogenCompleted
Clinical Trials on Lumbar injection
-
Keimyung University Dongsan Medical CenterCompleted
-
Marmara UniversityNot yet recruitingLumbar Spinal StenosisTurkey (Türkiye)
-
Minia UniversityCompletedLumbar RadiculopathyEgypt
-
Vertos Medical, Inc.CompletedLumbar Spinal StenosisUnited States
-
Mersin UniversityNot yet recruitingLumbar Disc Disease | Radiculopathy Lumbar | Radicular PainTurkey (Türkiye)
-
Kenneth D CandidoCompletedUnilateral Lumbosacral Radiculopathy PainUnited States
-
Oznur UzunCompletedLow Back Pain, Mechanical | Facet Syndrome of Lumbar SpineTurkey
-
Santiago Garcia-HernandezCompletedLow Back Pain | Chronic Pain | Analgesia, Epidural | Pain Measurement | Clinic, PainSpain
-
Womack Army Medical CenterUniformed Services University of the Health Sciences; The Geneva FoundationCompletedFacet Joint Pain; Low Back PainUnited States
-
Coastal Orthopedics & Sports MedicineVertos Medical, Inc.Completed